Antithrombotic use and bleeding risk in patients with atrial fibrillation: findings from a multipayer analysis.

Abstract:

AIMS:To analyze administrative claims data from Medicaid, Medicare and commercial insurance sources to estimate stroke risk, bleeding risk, and the use of antithrombotic treatment in patients with atrial fibrillation (AF). METHODS:Included patients were aged ≥18 years with a new or existing diagnosis of AF. Outcomes were assessed over 1 year and included stroke risk (CHADS2/CHA2DS2-VASc score), bleeding risk (ATRIA score) and anticoagulant use. RESULTS:A total of 115,906 patients with AF met inclusion criteria between six databases. Among patients with high stroke risk (CHADS2 ≥2) and low bleeding risk (ATRIA 0-3), 42-82% did not receive an antithrombotic. CONCLUSION:Levels of thromboprophylaxis for high-risk AF patients in real-world data differ significantly from current medical guidelines for stroke prevention.

journal_name

J Comp Eff Res

authors

Lang K,Federico V,Patel AA,Munsell M,Nelson WW,Owens G,Mody SH,Schein J,Menzin J

doi

10.2217/cer.15.48

subject

Has Abstract

pub_date

2016-01-01 00:00:00

pages

39-48

issue

1

eissn

2042-6305

issn

2042-6313

journal_volume

5

pub_type

杂志文章
  • The utilization of telephone follow-up in the advanced cancer population: a review of the literature.

    abstract:BACKGROUND:Palliative cancer patients often require clinic or hospital follow-up after any treatment intervention they may have received. This is typically done in person at either a hospital or a clinic. In these advanced cancer patients, this may be burdensome and result in attrition. Telephone follow-up is becoming ...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章,评审

    doi:10.2217/cer.12.63

    authors: Zhou M,Holden L,Bedard G,Zeng L,Lam H,Chu D,Lao N,Lauzon N,Chow E

    更新日期:2012-11-01 00:00:00

  • Comparison of amlodipine versus other calcium channel blockers on blood pressure variability in hypertensive patients in China: a retrospective propensity score-matched analysis.

    abstract:AIM:Reducing the fluctuation of blood pressure has recently been recognized as a potential target for improving management of hypertension to prevent cardiovascular events, particularly for strokes. Some randomized controlled trials demonstrated that amlodipine can effectively reduce blood pressure as a well-establishe...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章,多中心研究

    doi:10.2217/cer-2017-0063

    authors: Zhang L,Yang J,Li L,Liu D,Xie X,Dong P,Lin Y

    更新日期:2018-07-01 00:00:00

  • Matching-adjusted indirect comparison: secukinumab versus infliximab in biologic-naive patients with psoriatic arthritis.

    abstract::Aim: To compare secukinumab with infliximab in biologic-naive patients with psoriatic arthritis using matching-adjusted indirect comparison. Patients & methods: Individual patient baseline data for secukinumab were matched to published aggregate data for infliximab by key baseline characteristics, with matching weight...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章

    doi:10.2217/cer-2018-0141

    authors: Strand V,McInnes I,Mease P,Nash P,Thom H,Kalyvas C,Hunger M,Gandhi K,Pricop L,Jugl S,Choy E

    更新日期:2019-05-01 00:00:00

  • Study protocol for the dabigatran, apixaban, rivaroxaban, edoxaban, warfarin comparative effectiveness research study.

    abstract::Since 2010, four oral anticoagulants have been approved for marketing in addition to warfarin for treatment of thromboembolic disease. Limited head-to-head data exist comparing these treatments, leaving patients and clinicians with little guidance for selecting a strategy that balances recurrence reduction with bleedi...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章

    doi:10.2217/cer-2017-0053

    authors: Krumme AA,Pawar A,Schneeweiss S,Glynn RJ,Choudhry NK,Kulldorff M,Ortiz AS,Avorn J,Gagne JJ

    更新日期:2018-01-01 00:00:00

  • Experiences of cancer patients with outpatient care in the USA: a population-based study.

    abstract::Aim: To evaluate the patterns of cancer patients-assessed quality of outpatient care in the USA. Materials & methods: Medical Expenditure Panel Survey datasets for the years 2011, 2013, 2015 and 2017 were accessed and adult participants with a history of cancer diagnosis were reviewed. Participants' assessments of dif...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章

    doi:10.2217/cer-2020-0124

    authors: Abdel-Rahman O

    更新日期:2020-09-01 00:00:00

  • Systematic overview of cost-effectiveness thresholds in ten countries across four continents.

    abstract:AIM:To provide an overview of thresholds for incremental cost-effectiveness ratios (ICERs) representing willingness-to-pay (WTP) across multiple countries and insights into exemptions pertaining to the ICER (e.g., cancer). To compare ICER thresholds to individual country's estimated ability-to-pay. MATERIALS & METHODS...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章

    doi:10.2217/cer.15.38

    authors: Schwarzer R,Rochau U,Saverno K,Jahn B,Bornschein B,Muehlberger N,Flatscher-Thoeni M,Schnell-Inderst P,Sroczynski G,Lackner M,Schall I,Hebborn A,Pugner K,Fehervary A,Brixner D,Siebert U

    更新日期:2015-09-01 00:00:00

  • No protocol and no liability: a call for COVID crisis guidelines that protect vulnerable populations.

    abstract::The COVID-19 pandemic is revealing the unacceptable health disparities across New York City and in this country. The mortality rates of vulnerable and minority populations alone suggest a need to re-evaluate clinical decision making protocols, especially given the recently passed Emergency or Disaster Treatment Protec...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章

    doi:10.2217/cer-2020-0090

    authors: Caraccio C,White RS,Jotwani R

    更新日期:2020-08-01 00:00:00

  • Survival in unresectable AJCC stage I and II HCC and the effect of DEB-TACE: SEER versus tertiary cancer center cohort study.

    abstract:AIM:To evaluate overall survival (OS) in unresectable American Joint Committee on Cancer (AJCC) stage I/II hepatocellular carcinoma (HCC) treated with drug-eluting-bead transarterial chemoembolization (DEB-TACE) versus best supportive care. MATERIALS & METHODS:OS in consecutive patients with AJCC stage I/II unresectab...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章

    doi:10.2217/cer.15.54

    authors: Xing M,Kokabi N,Prajapati HJ,Close O,Ludwig JM,Kim HS

    更新日期:2016-03-01 00:00:00

  • A meta-analysis platform methodology for determining the comparative effectiveness of antihepatitis C virus regimens.

    abstract:AIM:Many hepatitis C virus regimens are unlikely to be compared head to head. In more difficult to treat populations where there is no standard of care, trials are single arm. We describe a flexible meta-analysis platform in this setting. METHODS:Our meta-analysis is literature based. We illustrate our methodology and...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章,meta分析,评审

    doi:10.2217/cer.14.69

    authors: Broglio KR,Daar ES,Quintana M,Yuan Y,Kalsekar A,Spellberg B,Lewis RJ,Akker Dv,Detry MA,Le T,Berry SM

    更新日期:2015-03-01 00:00:00

  • Policy perspectives on alternative models for pharmaceutical rebates: a report from the Institute for Clinical and Economic Review Policy Summit.

    abstract::Alternative approaches to the current rebate system are being considered by policymakers and stakeholders in the private insurance market. This paper presents an analysis of three alternative options to the current rebate model: retaining retroactive rebates but requiring 100% pass-through of rebates and fees to plan ...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章

    doi:10.2217/cer-2019-0094

    authors: Pearson SD,Segel C,Cole A,Henshall C,Towse A

    更新日期:2019-10-01 00:00:00

  • Building useful evidence: changing the clinical research paradigm to account for comparative effectiveness research.

    abstract::Comparative effectiveness research (CER) calls for substantial changes in the way clinical research is conducted, interpreted and practically applied in the USA, in order to produce useful clinical evidence. Departing from classic efficacy and effectiveness research, the evolving CER paradigm requires structural and s...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章,评审

    doi:10.2217/CER.12.23

    authors: Greenfield S,Kaplan SH

    更新日期:2012-05-01 00:00:00

  • Dissemination and implementation of comparative effectiveness evidence: key informant interviews with Clinical and Translational Science Award institutions.

    abstract:AIM:To identify ongoing practices and opportunities for improving national comparative effectiveness research (CER) translation through dissemination and implementation (D&I) via NIH-funded Clinical and Translational Science Award (CTSA) institutions. MATERIALS & METHODS:Key informant interviews were conducted with 18...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章

    doi:10.2217/cer.13.10

    authors: Morrato EH,Concannon TW,Meissner P,Shah ND,Turner BJ

    更新日期:2013-03-01 00:00:00

  • When is evidence sufficient for decision-making? A framework for understanding the pace of evidence adoption.

    abstract::Translation of medical evidence into practice has not kept pace with the growth of medical technology and knowledge. We present three case studies--statins, drug eluting stents and bone marrow transplantation for breast cancer--to propose a framework for describing five factors that may influence the rate of adoption....

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章

    doi:10.2217/cer.13.39

    authors: Dubois RW,Lauer M,Perfetto E

    更新日期:2013-07-01 00:00:00

  • Reporting and analyses of sex/gender and race/ethnicity in randomized controlled trials of interventions published in the highest-ranking anesthesiology journals.

    abstract::Aim: We assessed reporting of data on sex/gender and race/ethnicity in randomized controlled trials of interventions published in the highest-ranking anesthesiology journals from 2014 to 2017. Methods: We extracted data regarding terminology for sex/gender, proportion of participants according to the race/gender and r...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章

    doi:10.2217/cer-2019-0071

    authors: Begic D,Janda-Martinac C,Vrdoljak M,Puljak L

    更新日期:2019-12-01 00:00:00

  • Importance of assessing and adjusting for cross-study heterogeneity in network meta-analysis: a case study of psoriasis.

    abstract:AIM:The importance of adjusting for cross-study heterogeneity when conducting network meta-analyses (NMAs) was demonstrated using a case study of biologic therapies for moderate-to-severe plaque psoriasis. METHODS:Bayesian NMAs were conducted for Psoriasis Area and Severity Index 90 response. Several covariates were c...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章

    doi:10.2217/cer-2018-0065

    authors: Cameron C,Hutton B,Druchok C,McElligott S,Nair S,Schubert A,Situ A,Varu A,Villacorta R

    更新日期:2018-11-01 00:00:00

  • Approaches to the management of functional tricuspid regurgitation.

    abstract::Functional tricuspid regurgitation (FTR) is an acquired valvular abnormality that is most frequently encountered during the evaluation and operative management of left-sided heart failure and left heart valve disease. Observational studies have demonstrated that uncorrected significant FTR during mitral valve surgery ...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章

    doi:10.2217/cer.15.46

    authors: Rogers JH,Bolling SF

    更新日期:2015-11-01 00:00:00

  • Big data, advanced analytics and the future of comparative effectiveness research.

    abstract::The intense competition that accompanied the growth of internet-based companies ushered in the era of 'big data' characterized by major innovations in processing of very large amounts of data and the application of advanced analytics including data mining and machine learning. Healthcare is on the cusp of its own era ...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章

    doi:10.2217/cer.14.2

    authors: Berger ML,Doban V

    更新日期:2014-03-01 00:00:00

  • Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement.

    abstract::AIMS: Stakeholder engagement is fundamental to comparative effectiveness research (CER), but lacks consistent terminology. This paper aims to define stakeholder engagement and present a conceptual model for involving stakeholders in CER. MATERIALS #ENTITYSTARTX00026; METHODS: The definitions and model were developed f...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章

    doi:10.2217/cer.12.7

    authors: Deverka PA,Lavallee DC,Desai PJ,Esmail LC,Ramsey SD,Veenstra DL,Tunis SR

    更新日期:2012-03-01 00:00:00

  • Show me the money! An analysis of underserved stakeholders' funding priorities in Patient Centered Outcomes Research domains.

    abstract:AIM:Develop an accessible exercise to engage underserved populations about research funding priorities; analyze the criteria they use to prioritize research; contrast these criteria to those currently used by Patient Centered Outcomes Research Institute (PCORI). MATERIALS & METHODS:Academic and community partners coll...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章

    doi:10.2217/cer-2017-0008

    authors: Cargill SS,Baker LL,Goold SD

    更新日期:2017-07-01 00:00:00

  • Venous stenting for patients with outflow obstruction and leg ulcers: cost-effectiveness and budget impact analyses.

    abstract::Aim: To perform cost-effectiveness analysis (CEA) and budget impact analysis (BIA) comparing stenting to standard medical treatment (SMT) for the management of deep venous outflow obstruction and leg ulcers from the Italian Healthcare Service perspective. Materials & methods: A Markov model was developed to project co...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章

    doi:10.2217/cer-2020-0030

    authors: Rognoni C,Lugli M,Maleti O,Tarricone R

    更新日期:2020-07-01 00:00:00

  • The mixed randomized trial: combining randomized, pragmatic and observational clinical trial designs.

    abstract::Clinical trial designs often fail to deliver data that jointly satisfy evolving demands of both regulatory and reimbursement authorities. We propose a new multi-tiered trial design to integrate efficacy and effectiveness, and address the evolving needs of authorities. The mixed randomized trial allocates patients firs...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章

    doi:10.2217/cer-2016-0034

    authors: Alsop J,Scott M,Archey W

    更新日期:2016-11-01 00:00:00

  • Young adult and parent stakeholder perspectives on participation in patient-centered comparative effectiveness research.

    abstract:AIM:Explore perspectives of adolescent and young adult (AYA) and parent stakeholders regarding their engagement in comparative effectiveness research (CER) evaluating cholesterol screening and treatment strategies for 17-21 year olds. METHODS:All nine AYAs and parent stakeholders participating in a 20-member panel of ...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章

    doi:10.2217/cer-2016-0025

    authors: Saunders T,Mackie TI,Shah S,Gooding H,de Ferranti SD,Leslie LK

    更新日期:2016-08-01 00:00:00

  • Continuous infusion of levodopa-carbidopa intestinal gel in Parkinson's disease.

    abstract::Evaluation of: Olanow CW, Kieburtz K, Odin P et al. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study. Lancet Neurol. 13(2), 141-149 (2014). Levodopa-induced motor complications, including mot...

    journal_title:Journal of comparative effectiveness research

    pub_type: 评论,杂志文章

    doi:10.2217/cer.14.33

    authors: Guthikonda LN,Lyons KE,Pahwa R

    更新日期:2014-07-01 00:00:00

  • Welcome to the Journal of Comparative Effectiveness Research.

    abstract::As the Senior Editors of the Journal of Comparative Effectiveness Research (JCER) we are delighted to present you with the first issue of this exciting new publication, focusing on the socially and clinically impactful field of comparative effectiveness research (CER). ...

    journal_title:Journal of comparative effectiveness research

    pub_type:

    doi:10.2217/cer.11.13

    authors: Greenfield S,Rich E

    更新日期:2012-01-01 00:00:00

  • Engaging hard-to-reach patients in patient-centered outcomes research.

    abstract:AIMS:This study aimed to identify methods to engage hard-to-reach patients in the research process. MATERIALS & METHODS:With funding from the Patient-Centered Outcomes Research Institute (Washington, DC, USA), the University of Maryland (MD, USA) conducted 20 focus groups and one individual interview. The sample consi...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章

    doi:10.2217/cer.13.11

    authors: Kauffman KS,Dosreis S,Ross M,Barnet B,Onukwugha E,Mullins CD

    更新日期:2013-05-01 00:00:00

  • Comparison between oral and intravenous application of tranexamic acid for total hip arthroplasty: a meta-analysis.

    abstract:AIM:We conducted a meta-analysis to compare the efficacy and safety of oral and intravenous applications of tranexamic acid (TXA) in total hip arthroplasty (THA). MATERIALS & METHODS:Electronic databases, including PubMed, Cochrane CENTRAL, ScienceDirect and Embase, were searched to identify the studies comparing the ...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章,meta分析

    doi:10.2217/cer-2018-0120

    authors: Wang L,Cao JG,Liu J

    更新日期:2019-04-01 00:00:00

  • Using primary care electronic health record data for comparative effectiveness research: experience of data quality assessment and preprocessing in The Netherlands.

    abstract:AIM:Details of data quality and how quality issues were solved have not been reported in published comparative effectiveness studies using electronic health record data. METHODS:We developed a conceptual framework of data quality assessment and preprocessing and apply it to a study comparing angiotensin-converting enz...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章

    doi:10.2217/cer-2015-0022

    authors: Huang Y,Voorham J,Haaijer-Ruskamp FM

    更新日期:2016-07-01 00:00:00

  • Proximal gastrectomy versus total gastrectomy for adenocarcinoma of the esophagogastric junction: a meta-analysis.

    abstract::Aim: To compare efficacy between total gastrectomy (TG) and proximal gastrectomy (PG) for upper-third gastric cancer. Materials & methods: PubMed, Embase and Cochrane library were searched to select suitable researches. Stata was used for meta-analysis including 5-year overall survival rate, recurrence rate, complicat...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章,meta分析

    doi:10.2217/cer-2019-0016

    authors: Chen YC,Lu L,Fan KH,Wang DH,Fu WH

    更新日期:2019-07-01 00:00:00

  • Hospital cost impact of orbital atherectomy with angioplasty for critical limb ischemia treatment: a modeling approach.

    abstract:AIM:The incremental cost of peripheral orbital atherectomy system (OAS) plus balloon angioplasty (BA) versus BA-only for critical limb ischemia was estimated. MATERIALS & METHODS:A deterministic simulation model used clinical and healthcare utilization data from the CALCIUM 360° trial and current cost data. Incrementa...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章

    doi:10.2217/cer-2017-0070

    authors: Shammas NW,Boyes CW,Palli SR,Rizzo JA,Martinsen BJ,Kotlarz H,Mustapha JA

    更新日期:2018-04-01 00:00:00

  • Medicaid insurance status predicts postoperative mortality after total knee arthroplasty in state inpatient databases.

    abstract::Aim: Medicaid versus private primary insurance status may predict in-hospital mortality and morbidity after total knee arthroplasty (TKA). Materials & methods: Regression models were used to test our hypothesis in patients in the State Inpatient Database (SID) from five states who underwent primary TKA from January 20...

    journal_title:Journal of comparative effectiveness research

    pub_type: 杂志文章

    doi:10.2217/cer-2019-0027

    authors: Maman SR,Andreae MH,Gaber-Baylis LK,Turnbull ZA,White RS

    更新日期:2019-10-01 00:00:00